全文获取类型
收费全文 | 10780篇 |
免费 | 685篇 |
国内免费 | 69篇 |
专业分类
耳鼻咽喉 | 257篇 |
儿科学 | 238篇 |
妇产科学 | 169篇 |
基础医学 | 1711篇 |
口腔科学 | 255篇 |
临床医学 | 764篇 |
内科学 | 2099篇 |
皮肤病学 | 99篇 |
神经病学 | 741篇 |
特种医学 | 380篇 |
外国民族医学 | 1篇 |
外科学 | 2041篇 |
综合类 | 70篇 |
一般理论 | 6篇 |
预防医学 | 639篇 |
眼科学 | 796篇 |
药学 | 611篇 |
中国医学 | 14篇 |
肿瘤学 | 643篇 |
出版年
2023年 | 94篇 |
2022年 | 131篇 |
2021年 | 282篇 |
2020年 | 178篇 |
2019年 | 265篇 |
2018年 | 271篇 |
2017年 | 211篇 |
2016年 | 236篇 |
2015年 | 243篇 |
2014年 | 364篇 |
2013年 | 419篇 |
2012年 | 611篇 |
2011年 | 584篇 |
2010年 | 381篇 |
2009年 | 355篇 |
2008年 | 591篇 |
2007年 | 609篇 |
2006年 | 544篇 |
2005年 | 570篇 |
2004年 | 561篇 |
2003年 | 525篇 |
2002年 | 518篇 |
2001年 | 203篇 |
2000年 | 198篇 |
1999年 | 178篇 |
1998年 | 127篇 |
1997年 | 80篇 |
1996年 | 90篇 |
1995年 | 92篇 |
1994年 | 88篇 |
1993年 | 77篇 |
1992年 | 97篇 |
1991年 | 101篇 |
1990年 | 81篇 |
1989年 | 76篇 |
1988年 | 87篇 |
1987年 | 79篇 |
1986年 | 64篇 |
1985年 | 64篇 |
1984年 | 53篇 |
1983年 | 49篇 |
1982年 | 39篇 |
1981年 | 46篇 |
1980年 | 42篇 |
1979年 | 41篇 |
1975年 | 40篇 |
1928年 | 40篇 |
1926年 | 37篇 |
1925年 | 43篇 |
1924年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Cromb Amandine Le Loarer Franois Sitbon Maxime Italiano Antoine Stoeckle Eberhard Buy Xavier Kind Michle 《European radiology》2020,30(5):2413-2424
European Radiology - The strongest adverse prognostic factor in myxoid/round cell liposarcomas (MRC-LPS) is the presence of a round cell component above 5% within the tumor bulk. Its identification... 相似文献
2.
3.
4.
5.
6.
7.
Heung Bae Kim James J Pomposelli Craig W Lillehei Roger L Jenkins Maureen M Jonas Laura E Krawczuk Steven J Fishman 《Liver transplantation》2005,11(11):1389-1394
Extrahepatic portal vein thrombosis (EHPVT) may occur in children or adults and usually comes to clinical attention due to complications of portal hypertension such as variceal hemorrhage. A variety of standard surgical techniques exist to manage these patients, but when these fail surgical options are limited. We describe two novel portosystemic shunts that utilize the gonadal vein as an autologous conduit. Four patients were evaluated for EHPVT with variceal bleeding. None of the patients were candidates for a standard splenorenal shunt due to prior surgical procedures. The first patient underwent a left mesogonadal shunt and the remaining 3 patients underwent a right mesogonadal shunt. Postoperative ultrasound or computed tomography (CT) scan confirmed early patency of the shunt in each patient. There have been no further episodes of variceal hemorrhage with follow-up of 3.5 years in the child who underwent the left mesogonadal shunt, and 17, 19, and 20 months in the patients who underwent the right mesogonadal shunt. Three of the 4 shunts remain patent. One shunt thrombosis occurred in a patient homozygous for the Factor V Leiden mutation despite anticoagulation with coumadin. This is the first report of the successful use of the gonadal vein as an in situ conduit for constructing a portosystemic shunt. In conclusion, the right and left mesogonadal shunts may be useful as salvage operations for patients with EHPVT who have failed standard surgical shunt procedures. 相似文献
8.
Can carotid endarterectomy be justified? No 总被引:1,自引:0,他引:1
S Jonas 《Archives of neurology》1987,44(6):652-654
9.
Michael Hermansson Anders Ekedahl Jonas Ranstam Thomas Zilling 《BMC gastroenterology》2009,9(1):25-13
Background
Despite a decreasing incidence of peptic ulcer disease, most previous studies report a stabile incidence of ulcer complications. We wanted to investigate the incidence of peptic ulcer complications in Sweden before and after the introduction of the proton pump inhibitors (PPI) in 1988 and compare these data to the sales of non-steroid anti-inflammatory drugs (NSAID) and acetylsalicylic acid (ASA). 相似文献10.
Jenny Andersson Barbro Linderholm Jonas Bergh Goran Elmberger 《Applied immunohistochemistry & molecular morphology》2004,12(1):14-20
We have studied the intratumor HER-2/neu heterogeneity in 78 consecutive and population-based primary invasive breast carcinomas. Within the invasive component, heterogeneity was detected in only 1 of 78 tumors. In 48 tumors (62%), we found both in situ and invasive components in analyzed tissue sections. Twelve of these 48 tumors had a difference of at least 2 arbitrary units in the in situ compared with the invasive part of the tumor with regard to the HER-2/neu status analyzed by HercepTest (immunohistochemistry). Eight of these 12 tumors were reanalyzed with fluorescent in situ hybridization and immunohistochemistry with and without a new Automated Cellular Imaging System. In this limited material, immunohistochemistry in combination with the Automated Cellular Imaging System seemed to have a better correlation with fluorescent in situ hybridization than immunostaining analyzed manually. In conclusion, HER-2/neu expression is not seldom heterogeneous in invasive compared with in situ components within a tumor. This finding should be considered in the choice of evaluation method. To avoid heterogeneity as a confounding factor in HER-2/neu analyses, detection methods such as immunohistochemistry and fluorescent in situ hybridization, which can provide evaluation in a preserved tissue architecture, should be used. Perhaps the intratumor HER-2/neu heterogeneity can explain some of the unexpected failures of trastuzumab therapy. 相似文献